169 related articles for article (PubMed ID: 17699291)
1. Clinical outcome of thrombotic microangiopathy after living-donor liver transplantation treated with plasma exchange therapy.
Nishi H; Hanafusa N; Kondo Y; Nangaku M; Sugawara Y; Makuuchi M; Noiri E; Fujita T
Clin J Am Soc Nephrol; 2006 Jul; 1(4):811-9. PubMed ID: 17699291
[TBL] [Abstract][Full Text] [Related]
2. De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy.
Schwimmer J; Nadasdy TA; Spitalnik PF; Kaplan KL; Zand MS
Am J Kidney Dis; 2003 Feb; 41(2):471-9. PubMed ID: 12552512
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of thrombotic microangiopathy following ABO incompatible living donor liver transplantation.
Miyata R; Shimazu M; Tanabe M; Kawachi S; Hoshino K; Wakabayashi G; Kawai Y; Kitajima M
Liver Transpl; 2007 Oct; 13(10):1455-62. PubMed ID: 17902122
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic microangiopathy after ABO-incompatible living donor liver transplantation: a case report.
Oya H; Sato Y; Yamamoto S; Nakatsuka H; Kobayashi T; Watanabe T; Kokai H; Hatakeyama K
Transplant Proc; 2008 Oct; 40(8):2549-51. PubMed ID: 18929797
[TBL] [Abstract][Full Text] [Related]
5. Plasma exchange therapy for thrombotic thrombocytopenic purpura in pediatric patients with liver transplantation.
Lee CH; Chen CL; Lin CC; Yang CH; Cheng YF; Wang MC; Eng HL; Liu PP; Chuang FR
Transplant Proc; 2008 Oct; 40(8):2554-6. PubMed ID: 18929799
[TBL] [Abstract][Full Text] [Related]
6. Outcome and prognosis of severe thrombotic microangiopathies treated by plasma exchange.
Federici L; Klouche K; Amigues L; Kanouni T; Lopez-Martinez E; Latry P; Beraud JJ; Rossi JF
Med Sci Monit; 2006 Jul; 12(7):CR302-7. PubMed ID: 16810135
[TBL] [Abstract][Full Text] [Related]
7. Living donor liver transplantation for primary biliary cirrhosis: retrospective analysis of 50 patients in a single center.
Hasegawa K; Sugawara Y; Imamura H; Ikeda M; Kokudo N; Makuuchi M
Transpl Int; 2005 Jul; 18(7):794-9. PubMed ID: 15948857
[TBL] [Abstract][Full Text] [Related]
8. Management of thrombotic microangiopathy following allogeneic transplantation: what is the role of plasma exchange?
Llamas P; Romero R; Cabrera R; Sanjuán I; Forés R; Fernández MN
Bone Marrow Transplant; 1997 Aug; 20(4):305-6. PubMed ID: 9285545
[TBL] [Abstract][Full Text] [Related]
9. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database.
Jakab SS; Navarro VJ; Colombe BW; Daskalakis C; Herrine SK; Rossi S
Liver Transpl; 2007 Oct; 13(10):1405-13. PubMed ID: 17902126
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative blood loss during living donor liver transplantation: an analysis of 635 recipients at a single center.
Yuasa T; Niwa N; Kimura S; Tsuji H; Yurugi K; Egawa H; Tanaka K; Asano H; Maekawa T
Transfusion; 2005 Jun; 45(6):879-84. PubMed ID: 15934985
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for invasive aspergillosis in living donor liver transplant recipients.
Osawa M; Ito Y; Hirai T; Isozumi R; Takakura S; Fujimoto Y; Iinuma Y; Ichiyama S; Tanaka K; Mishima M
Liver Transpl; 2007 Apr; 13(4):566-70. PubMed ID: 17394155
[TBL] [Abstract][Full Text] [Related]
12. Time course of organ dysfunction in thrombotic microangiopathy patients receiving either plasma perfusion or plasma exchange.
Darmon M; Azoulay E; Thiery G; Ciroldi M; Galicier L; Parquet N; Veyradier A; Le Gall JR; Oksenhendler E; Schlemmer B
Crit Care Med; 2006 Aug; 34(8):2127-33. PubMed ID: 16763519
[TBL] [Abstract][Full Text] [Related]
13. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation.
Ikegami T; Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Harada N; Iguchi T; Hashimoto N; Maehara Y
Transplantation; 2009 Aug; 88(3):303-7. PubMed ID: 19667930
[TBL] [Abstract][Full Text] [Related]
14. Early postoperative renal dysfunction in the adult living donor liver transplantation.
Lee SK; Park JB; Kim SJ; Choi GS; Kim DJ; Kwon CH; Lee SK; Joh JW
Transplant Proc; 2007 Jun; 39(5):1517-9. PubMed ID: 17580177
[TBL] [Abstract][Full Text] [Related]
15. Postoperative hyperbilirubinemia and graft outcome in living donor liver transplantation.
Marubashi S; Dono K; Nagano H; Asaoka T; Hama N; Kobayashi S; Miyamoto A; Takeda Y; Umeshita K; Monden M
Liver Transpl; 2007 Nov; 13(11):1538-44. PubMed ID: 17969209
[TBL] [Abstract][Full Text] [Related]
16. Thrombotic microangiopathy in transplantation and malignancy.
Qu L; Kiss JE
Semin Thromb Hemost; 2005 Dec; 31(6):691-9. PubMed ID: 16388420
[TBL] [Abstract][Full Text] [Related]
17. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area.
Cuellar-Rodriguez J; Avery RK; Lard M; Budev M; Gordon SM; Shrestha NK; van Duin D; Oethinger M; Mawhorter SD
Clin Infect Dis; 2009 Sep; 49(5):710-6. PubMed ID: 19635026
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary and blood stream infections in adult living donor and cadaveric liver transplant patients.
Saner FH; Olde Damink SW; Pavlakovic G; van den Broek MA; Rath PM; Sotiropoulos GC; Radtke A; Canbay A; Paul A; Nadalin S; Malagó M; Broelsch CE
Transplantation; 2008 Jun; 85(11):1564-8. PubMed ID: 18551060
[TBL] [Abstract][Full Text] [Related]
19. Surgical complications and outcome of living related liver transplantation.
Ho MC; Wu YM; Hu RH; Ko WJ; Ni YH; Chang MH; Yang PM; Lai MY; Lin MH; Lin HY; Lee PH
Transplant Proc; 2004 Oct; 36(8):2249-51. PubMed ID: 15561208
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa infection after living-donor liver transplantation in adults.
Hashimoto M; Sugawara Y; Tamura S; Kaneko J; Matsui Y; Kokudo N; Makuuchi M
Transpl Infect Dis; 2009 Feb; 11(1):11-9. PubMed ID: 18811632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
